Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19

INTRODUCTION: The ID NOW is FDA approved for the detection of SARS-CoV-2 in symptomatic individuals within the first 7 days of symptom onset for COVID-19 if tested within 1 h of specimen collection. GAP STATEMENT: Clinical data on the performance of the ID NOW are limited, with many studies varying...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokes, William, Berenger, Byron M., Singh, Takshveer, Adeghe, Ifueko, Schneider, Angela, Portnoy, Danielle, King, Teagan, Scott, Brittney, Pabbaraju, Kanti, Shokoples, Sandy, Wong, Anita A., Gill, Kara, Turnbull, LeeAnn, Hu, Jia, Tipples, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2021
Materias:
Clinical Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493423/
https://www.ncbi.nlm.nih.gov/pubmed/34309503
http://dx.doi.org/10.1099/jmm.0.001372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493423/
https://www.ncbi.nlm.nih.gov/pubmed/34309503
http://dx.doi.org/10.1099/jmm.0.001372

Ejemplares similares